CompaniesByCap
DNA
Ginkgo Bioworks Holdings Inc. (DNA)
NYSE · Healthcare

Ginkgo Bioworks Holdings Inc. Cash Flow 2019–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Operating Cash Flow-171.1M-319.6M-295.5M-252.2M-253.8M-135.8M-44.7M
Depreciation & Amort.59.0M63.0M70.5M42.6M29.1M13.9M10.8M
Investing Activities
Capital Expenditure7.7M62.5M40.8M52.3M56.5M57.8M22.2M
Free Cash Flow-178.7M-382.1M-336.3M-304.5M-310.3M-193.7M-66.9M
Financing Activities
Dividends Paid
Stock Buybacks408,000

Ginkgo Bioworks Holdings Inc. Cash Flow — FAQ

Ginkgo Bioworks Holdings Inc. (DNA) cash flow over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DNA's cash flow history?

The chart and table above show Ginkgo Bioworks Holdings Inc.'s cash flow by year and by quarter, including the growth rate.